Study for Using Radiosurgery on Limited Metastases of Breast Cancer
Public ClinicalTrials.gov record NCT00167414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study for Using Radiosurgery on Limited Metastases of Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate whether radiosurgery, along with standard chemotherapy, immunotherapy (the treatment of cancer by modulating the immune system and immune response), or hormonal therapy, affects the quality and length of life. The standard therapy is surgery, radiation therapy, or chemotherapy alone or in any combination. A second purpose of this study is to determine if the levels of a special type of protein (called cytokines) found in the blood are related to the quality of life while on this treatment.
Study identification
- NCT ID
- NCT00167414
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Interventions
- Hypofractionated Stereotactic Body Radiation Therapy Procedure
- Hypofractionated Stereotactic Body Radiation Therapy Radiation
Procedure · Radiation
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2000
- Primary completion
- Oct 31, 2016
- Completion
- Oct 31, 2016
- Last update posted
- Jan 4, 2018
2000 – 2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Department of Radiation Oncology: University of Rochester | Rochester | New York | 14642 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Breast Cancer, Metastatic trials
Other public records listing Breast Cancer, Metastatic. Sorted by last update posted; newest first. Not a recommendation.
- NCT07635147: Decision Support Tool for Patients With Advanced Breast Cancer Recruiting
- NCT05142800: Screening For BCRL In Targeted Therapy For Breast Cancer Recruiting
- NCT07659652: Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease Not yet recruiting
- NCT06678269: A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer Recruiting
- NCT06663787: Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Patients Who Achieved Durable Response to Anti-HER2 Treatment Active, not recruiting
- NCT06750484: Trial of Trastuzumab Deruxtecan in Previously Treated HER2 Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00167414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2018 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00167414 live on ClinicalTrials.gov.